Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 Among Previously Infected Healthcare Personnel and First Responders

被引:21
作者
Akinbami, Lara J. [1 ,2 ]
Biggerstaff, Brad J. [3 ]
Chan, Philip A. [4 ]
McGibbon, Emily [5 ]
Pathela, Preeti [5 ]
Petersen, Lyle R. [3 ]
机构
[1] Natl Ctr Hlth Stat, Ctr Dis Control, Hyattsville, MD USA
[2] US PHS, Rockville, MD USA
[3] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA
[4] Rhode Isl Dept Hlth, Providence, RI 02908 USA
[5] New York City Dept Hlth & Mental Hyg, Queens, NY USA
关键词
SARS-CoV-2; reinfection; antibody; healthcare personnel; first responders; PUBLIC SAFETY PERSONNEL; WORKERS; USA;
D O I
10.1093/cid/ciab952
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Severe acute respiratory syndrome coronavirus 2 reinfection was uncommon among first responders and healthcare personnel before widespread variant circulation. Seropositivity was protective against reinfection. Exposure to household member(s) with coronavirus disease 2019 prior to serology testing was protective. Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus testing among first responders and healthcare personnel who participated in a May 2020-August 2020 serosurvey that assessed spike protein antibodies provided an opportunity to assess reinfection. Methods Serology survey data were merged with virus testing results from Rhode Island (1 March 2020-17 February 2021) and New York City (10 March 2020-14 December 2020). Participants with a positive virus test >= 14 days before their serology test were included. Reinfection was defined as a second positive SARS-CoV-2 test >= 90 days after the first positive test. The association between serostatus and reinfection was assessed with a proportional hazards model. Results Among 1572 previously infected persons, 40 (2.5%) were reinfected. Reinfection differed by serostatus: 8.4% among seronegative vs 1.9% among seropositive participants (P < .0001). Most reinfections occurred among Rhode Island nursing home and corrections personnel (n = 30) who were most frequently tested (mean 30.3 tests vs 4.6 for other Rhode Island and 2.3 for New York City participants). The adjusted hazard ratio (aHR) for reinfection in seropositive vs seronegative persons was 0.41 (95% confidence interval [CI], .20-.81). Exposure to a household member with coronavirus disease 2019 (COVID-19) before the serosurvey was also protective (aHR, 0.34; 95% CI, .13-.89). Conclusions Reinfections were uncommon among previously infected persons over a 9-month period that preceded widespread variant circulation. Seropositivity decreased reinfection risk. Lower reinfection risk associated with exposure to a household member with COVID-19 may reflect subsequently reduced household transmission.
引用
收藏
页码:E201 / E207
页数:7
相关论文
共 31 条
[21]   Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers [J].
Lumley, S. F. ;
O'Donnell, D. ;
Stoesser, N. E. ;
Matthews, P. C. ;
Howarth, A. ;
Hatch, S. B. ;
Marsden, B. D. ;
Cox, S. ;
James, T. ;
Warren, F. ;
Peck, L. J. ;
Ritter, T. G. ;
de Toledo, Z. ;
Warren, L. ;
Axten, D. ;
Cornall, R. J. ;
Jones, E. Y. ;
Stuart, D. I. ;
Screaton, G. ;
Ebner, D. ;
Hoosdally, S. ;
Chand, M. ;
Crook, D. W. ;
O'Donnell, A. -M. ;
Conlon, C. P. ;
Pouwels, K. B. ;
Walker, A. S. ;
Peto, T. E. A. ;
Hopkins, S. ;
Walker, T. M. ;
Jeffery, K. ;
Eyre, D. W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (06) :533-540
[22]   Predictors of severe symptomatic laboratory-confirmed SARS-CoV-2 reinfection [J].
Murillo-Zamora, E. ;
Mendoza-Cano, O. ;
Delgado-Enciso, I ;
Hernandez-Suarez, C. M. .
PUBLIC HEALTH, 2021, 193 :113-115
[23]   Lack of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Large Cohort of Previously Infected Persons [J].
Petersen, Lyle R. ;
Sami, Samira ;
Vuong, Nga ;
Pathela, Preeti ;
Weiss, Don ;
Morgenthau, Beth Maldin ;
Henseler, Rebecca A. ;
Daskalakis, Demetre C. ;
Atas, Jenny ;
Patel, Anita ;
Lukacs, Susan ;
Mackey, Lisa ;
Grohskopf, Lisa A. ;
Thornburg, Natalie ;
Akinbami, Lara J. .
CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) :E3066-E3073
[24]   Duration of SARS-CoV-2 shedding: A population-based, Canadian study [J].
Phillips, Susan P. ;
Wei, Xuejiao ;
Kwong, Jeffrey C. ;
Gubbay, Jonathan ;
Schwartz, Kevin L. ;
Majury, Anna ;
Groome, Patti A. .
PLOS ONE, 2021, 16 (06)
[25]   Prevalence of SARS-CoV-2 Antibodies in First Responders and Public Safety Personnel, New York City, New York, USA, May-July 2020 [J].
Sami, Samira ;
Akinbami, Lara J. ;
Petersen, Lyle R. ;
Crawley, Addie ;
Lukacs, Susan L. ;
Weiss, Don ;
Henseler, Rebecca A. ;
Vuong, Nga ;
Mackey, Lisa ;
Patel, Anita ;
Grohskopf, Lisa A. ;
Morgenthau, Beth Maldin ;
Daskalakis, Demetre ;
Pathela, Preeti .
EMERGING INFECTIOUS DISEASES, 2021, 27 (03) :796-804
[26]   Epidemiology, clinical characteristics, household transmission, and lethality of severe acute respiratory syndrome coronavirus-2 infection among healthcare workers in Ontario, Canada [J].
Schwartz, Kevin L. ;
Achonu, Camille ;
Buchan, Sarah A. ;
Brown, Kevin A. ;
Lee, Brenda ;
Whelan, Michael ;
Wu, Julie H. C. ;
Garber, Gary .
PLOS ONE, 2020, 15 (12)
[27]   Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection of a Healthcare Worker in a Belgian Nosocomial Outbreak Despite Primary Neutralizing Antibody Response [J].
Selhorst, Philippe ;
van Ierssel, Sabrina H. ;
Michiels, Jo ;
Marien, Joachim ;
Bartholomeeusen, Koen ;
Dirinck, Eveline ;
Vandamme, Sarah ;
Jansens, Hilde ;
Arien, Kevin K. .
CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) :E2985-E2991
[28]   Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium [J].
Steensels, Deborah ;
Oris, Els ;
Coninx, Laura ;
Nuyens, Dieter ;
Delforge, Marie-Luce ;
Vermeersch, Pieter ;
Heylen, Line .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (02) :195-197
[29]   Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study [J].
To, Kelvin Kai-Wang ;
Tsang, Owen Tak-Yin ;
Leung, Wai-Shing ;
Tam, Anthony Raymond ;
Wu, Tak-Chiu ;
Lung, David Christopher ;
Yip, Cyril Chik-Yan ;
Cai, Jian-Piao ;
Chan, Jacky Man-Chun ;
Chik, Thomas Shiu-Hong ;
Lau, Daphne Pui-Ling ;
Choi, Chris Yau-Chung ;
Chen, Lin-Lei ;
Chan, Wan-Mui ;
Chan, Kwok-Hung ;
Ip, Jonathan Daniel ;
Ng, Anthony Chin-Ki ;
Poon, Rosana Wing-Shan ;
Luo, Cui-Ting ;
Cheng, Vincent Chi-Chung ;
Chan, Jasper F. W. ;
Hung, Ivan Fan-Ngai ;
Chen, Zhiwei ;
Chen, Honglin ;
Yuen, Kwok-Yung .
LANCET INFECTIOUS DISEASES, 2020, 20 (05) :565-574
[30]   Duration of Viral Shedding of Discharged Patients With Severe COVID-19 [J].
Zhou, Bo ;
She, Jianqing ;
Wang, Yadan ;
Ma, Xiancang .
CLINICAL INFECTIOUS DISEASES, 2020, 71 (16) :2240-2242